Related Experiment Video
Updated: May 23, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
[Recent advances in imaging in Parkinson disease]
1Department of Neurology, Tohoku University School of Medicine, Aoba-ku, Sendai, Japan.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|April 7, 2012
Summary
Advanced imaging techniques offer new hope for early Parkinson disease diagnosis. These methods reveal subtle brain changes, aiding in detecting the condition before symptoms appear and tracking its progression.
Area of Science:
- Neurology
- Radiology
- Biomarker Discovery
Context:
- Early and precise diagnosis of Parkinson disease remains a significant clinical challenge.
- Pathophysiology of Parkinson disease is increasingly understood, yet diagnostic limitations persist.
- In vivo imaging biomarkers are crucial for assessing Parkinson disease.
Purpose:
- To review current imaging techniques for studying Parkinson disease.
- To highlight the role of imaging in diagnosing and monitoring Parkinson disease.
- To explore how imaging reveals structural, metabolic, and neurochemical changes.
Summary:
- Structural MRI with voxel-based morphometry shows gray matter loss in Parkinson disease.
- Fluorodeoxyglucose-positron emission tomography (FDG-PET) identifies network abnormalities.
- Radiotracer imaging assesses dopaminergic and non-dopaminergic systems, crucial for nigro-striatal integrity.
Impact:
- Imaging can detect presymptomatic Parkinson disease.
- These techniques enable monitoring of disease progression.
- Imaging data provide critical insights into Parkinson disease pathology.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:19Imaging Studies VII: Vascular Imaging
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...